Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP873263.RAO7TJa5pPMNmvT188UmXYKzOYsvrkPNpV4wDKVO9BhU4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP873263.RAO7TJa5pPMNmvT188UmXYKzOYsvrkPNpV4wDKVO9BhU4130_assertion type Assertion NP873263.RAO7TJa5pPMNmvT188UmXYKzOYsvrkPNpV4wDKVO9BhU4130_head.
- NP873263.RAO7TJa5pPMNmvT188UmXYKzOYsvrkPNpV4wDKVO9BhU4130_assertion description "[In each category except for RARS, approximately half of the patients progressed, with a slightly less median time to progression in RAEB-T than for the other subtypes of MDS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP873263.RAO7TJa5pPMNmvT188UmXYKzOYsvrkPNpV4wDKVO9BhU4130_provenance.
- NP873263.RAO7TJa5pPMNmvT188UmXYKzOYsvrkPNpV4wDKVO9BhU4130_assertion evidence source_evidence_literature NP873263.RAO7TJa5pPMNmvT188UmXYKzOYsvrkPNpV4wDKVO9BhU4130_provenance.
- NP873263.RAO7TJa5pPMNmvT188UmXYKzOYsvrkPNpV4wDKVO9BhU4130_assertion SIO_000772 11960342 NP873263.RAO7TJa5pPMNmvT188UmXYKzOYsvrkPNpV4wDKVO9BhU4130_provenance.
- NP873263.RAO7TJa5pPMNmvT188UmXYKzOYsvrkPNpV4wDKVO9BhU4130_assertion wasDerivedFrom befree-20150227 NP873263.RAO7TJa5pPMNmvT188UmXYKzOYsvrkPNpV4wDKVO9BhU4130_provenance.
- NP873263.RAO7TJa5pPMNmvT188UmXYKzOYsvrkPNpV4wDKVO9BhU4130_assertion wasGeneratedBy ECO_0000203 NP873263.RAO7TJa5pPMNmvT188UmXYKzOYsvrkPNpV4wDKVO9BhU4130_provenance.